[Pharmacological considerations on drugs used in non-inflammatory vestibular syndromes].
D004232:Diuretics / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007759:Labyrinth Diseases / Q000188:drug therapy*; D008575:Meniere Disease / Q000188:drug therapy; D011343:Procaine / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014652:Vascular Diseases / Q000150:complications; D014665:Vasodilator Agents / Q000627:therapeutic use; D014722:Vestibule, Labyrinth / Q000187:drug effects*
D004232:Diuretics; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D013565:Sympatholytics; D014149:Tranquilizing Agents; D014665:Vasodilator Agents; D011343:Procaine; D004837:Epinephrine
Consideraţii farmacologice asupra medicaţei utilizate în sindroamele vestibulare neinflamatorii.